FDAs concerns with unapproved GLP-1 drugs used for weight loss, United States Food and Drug Administration (2024) FDA approves first oral GLP-1 treatment for Type 2 diabetes, United States Food and Drug Administration (2019) Semaglutide for Type 2 diabetes, CADTH Health Technology Review (2023) Anti-inflammatory benefits of semaglutide: State of the art, Journal of Clinical & Translational Endocrinology (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
such approaches must be expanded across other relevant disciplines
For these reasons, some people should not take Ozempic, such as those with a personal or family history of pancreas problems, diabetic retinopathy, severe stomach problems, or women who are currently pregnant or plan to become pregnant
Press lightly and it should stop
And if youve got multiple pens or vials on hand, its a good idea to rotate them so youre always using the ones closest to their expiration date first
